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Abstract 
Review on t(9;17)(p13;p12) PAX5/NCOR1, with 
data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
B-cell acute lymphoblastic leukemia (B-ALL) 
Epidemiology 
One case to date, a 2-year-old boy with a CD10+ 
(B-II, common) ALL (Coyaud et al., 2010). 
Prognosis 
No data. 






391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391). 
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide. Involved in B-cell differentiation. Entry 
of common lymphoid progenitors into the B cell 
lineage depends on E2A, EBF1, and PAX5;  
activates B-cell specific genes and repress genes 
involved in other lineage commitments. Activates 
the surface cell receptor CD19 and repress FLT3. 
Pax5 physically interacts with the RAG1/RAG2 
complex, and removes the inhibitory signal of the 
lysine-9-methylated histone H3, and induces V-to-
DJ rearrangements. Genes repressed by PAX5 
expression in early B cells are restored in their 
function in mature B cells and plasma cells, and 
PAX5 repressed (Fuxa et al., 2004; Johnson et al., 
2004; Zhang et al., 2006; Cobaleda et al., 2007; 





2440 amino acids; from N-term to C-term, NCOR1 
contains: a repression domains (responsible for the 
repressive activity of the corepressor) (aa 1-312); a 
poly-Gln stretch (aa 58-64), two coiled coil 
domains (aa 174-216 and aa 299-328); a SANT 
(Swi3, Ada2, NCoR1, TFIIB) domain (deacetylase 
activation domain (DAD)) (aa 435-486); a coiled 
coil domain (aa 501-557); a poly-Ala stretch (aa 
593-603); a Pro-rich stretch (aa 607-617); a SANT 
domain (histone interaction domain (HID)) (aa 623-
674); a poly-Pro stretch (aa 1032-1035); a poly-Ala 
stretch (aa 1707-1712); a CoRNR box motif (Leu-
x-x-Leu-Leu motifs) (aa 1933-1937); a poly-Ser 
stretch (aa 1952-1963); a nuclear receptor-
interacting domain ID1 (aa 2032-2115); a CoRNR 
box motif (aa 2055-2059); another nuclear receptor-
interacting domain ID2 (aa 2212-2273); and a 
CoRNR box motif (aa 2263-2267). 
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PAX5-NCOR1 fusion protein. 
 
NCOR1 and NCOR2 (12q24, also called SMRT) 
are transcriptional corepressors that associate with 
nuclear hormone receptors (thyroid hormone 
receptors and retinoic acid receptors) in the absence 
of ligand. 
Thyroid hormone receptors interact specifically 
with the ID3 and ID2 domains of NCOR1 (ID 
domains contain an isoleucine-rich domain, named 
the CoRNR box, this CoRNR box is required for 
nuclear hormone receptors interaction). SANT-like 
domains promote histone deacetylation. Repression 
is mediated by formation of a large corepressor 
complex that contains SIN3A/B (15q24 and 
19p13), recruiting multiple histone deacetylase 
enzymes such as HDAC1 (1p35), HDAC2 (6q21), 
HDAC3 (5q31), HDAC4 (2q37), HDAC7 (12q13), 
and SIRT1 (10q21), resulting in the formation of 
repressive chromatin structures. This complex 
associates with the thyroid hormone receptor and 
the retinoic acid receptor. 
NCOR1 and NCOR2 also interact with many other 
transcription factors including: BCL6 (3q27), 
RUNX1T1 (8q21, also called ETO), SPEN (1p36, 
also called SHARP), ZBTB33 (Xq24), HEXIM1 
(17q21), TBL1XR1 (3q26), MEF2C (5q14), 
CNOT2 (12q15), and RBJP (4p15), Jun proteins 
and the NFKB pathway (Li et al., 1997; Watson et 
al., 2012; Mottis et al., 2013). 




Fusion of PAX5 exon 5 to NCOR1 exon 43. 
Fusion protein 
Description 
415 amino acids. The predicted fusion protein 
contains the DNA binding paired domain, and the  
octapeptide of PAX5 (201 aa), and most the ID2 
region (containing the CoRNR box motif) of 
NCOR1 (214 aa). 
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